10x Genomics Inc

Financials

Total assets 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Total liabilities 190.27 M201.26 M223.24 M224.1 M208.5 M245.04 M Total equity 739.07 M817.57 M805.74 M741.04 M710.13 M796.33 M Total liabilities & shareholders' equities 929.34 M1.02 B1.03 B965.14 M918.64 M1.04 B Total debt 0————— Net debt -600.63 M—————

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

TXG

Financials

10x Genomics Inc

Haberler

Stock Picks From Seeking Alpha's March 2026 New Analysts

10x Genomics hissesi 23,6 dolarda 52 haftalık zirve yaptı

Canada stocks higher at close of trade; S&P/TSX Composite up 0.58%

William Blair, 10X Genomics hissesi için tavsiyesini yükseltti

Tempus AI Reinforces Market Position With Collaborations in 2026

Bioptimus, 10x Genomics ile uzamsal biyoloji atlası başlattı

Cathie Wood’un ARK’ı Twist Bioscience sattı, Circle aldı

10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG)

Cathie Wood’un ARK’ı Bullish hissesi sattı, 10X Genomics aldı

Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story

Cathie Wood’un ARK’ı Circle Internet hissesi sattı, Figma aldı

Microsoft’un yapay zeka modeli spatialomics hisselerinde satışa yol açtı